Merck & Co INC New Com (MRK) Shareholder Kings Point Capital Management Decreased Stake by $3.11 Million

May 3, 2018 - By Matthew Medley

Merck & Co., Inc. (NYSE:MRK) Corporate LogoBig Money Sentiment decreased to 0.94 in Q4 2017. It has change of 0.12, from 2017Q3’s 1.06. The ratio dived due to MRK positioning: 94 sold and 631 reduced. 123 funds amassed positions and 558 increased positions. Investors holded 1.96 billion in 2017Q3 but now own 1.93 billion shares or 1.34% less. Baker Ellis Asset Mngmt Ltd Liability Company has 28,669 shs for 0.41% of their capital. Seabridge Inv Advisors Ltd Liability holds 0.02% in Merck & Co., Inc. (NYSE:MRK) or 1,383 shs. Garde Capital reported 4,110 shs or 0.04% of all its holdings. Horizon Invests Llc has 14,982 shs. 11,992 were reported by Kazazian Asset Mgmt Lc. Eagle Glob Advsrs Ltd Liability holds 0.28% or 158,255 shs in its capital. Ledyard Bancshares reported 38,454 shs. At Financial Bank accumulated 10,867 shs. Daiwa Securities Grp Inc invested 0.05% of its capital in Merck & Co., Inc. (NYSE:MRK). 14,513 were accumulated by Independence Trust Co. Roffman Miller Associate Pa holds 15,848 shs. Nelson Van Denburg Campbell Wealth Mgmt Ltd Llc reported 0.13% stake. Counselors Inc reported 414,553 shs. First Citizens Retail Bank & Tru Co accumulated 20,652 shs or 0.16% of the stock. Numeric Ltd Liability Company invested in 0.07% or 167,150 shs.

The holdings In Merck & Co Inc New Com (MRK) was reduced held by Kings Point Capital Management. According to 2017Q4 Securities and Exchange filling the reduction is 91.62%. The company’s stock sank 4.63% while Kings Point Capital Management sold 55,501 shares. At the end of 2017Q4, the 5,079 shares of the health care company held by the institutional investor were priced at $286,000, down from 60,580 at the end of the previous reported quarter. $154.29B is Merck & Co Inc New Com’s market cap. The stock decreased 1.17% or $0.68 during the last trading session, hitting $57.3.Merck & Co., Inc. has volume of 10.42 million shares. Since May 3, 2017 MRK has declined 14.94% and is downtrending. MRK underperformed by 26.49% the S&P500.

Kings Point Capital Management has risen its stake in and also increased its holding in by shares in the quarter, for a total of shares.

Merck & Co., Inc. (NYSE:MRK) Ratings Coverage

A total of 14 analysts rate Merck & Company (NYSE:MRK) as follows: 11 “Buy”, 3 “Hold” and 0 “Sell”. Тherefore 79% are bullish. The firm has $7300 highest and $53.0 lowest target. The avg target $65.91 is 15.03% above the last ($57.3) price. (NYSE:MRK) has 23 ratings reports on May 3, 2018 according to StockzIntelligence. The company rating was upgraded by DZ Bank on Tuesday, February 13. On Wednesday, February 14 the stock has “Outperform” rating by BMO Capital Markets. In Thursday, November 16 report Jefferies maintained the stock with “Hold” rating. On Tuesday, November 28 the company was maintained by Bank of America. On Monday, February 5 the rating was maintained by Credit Suisse with “Outperform”. The stock rating was maintained by Jefferies with “Hold” on Tuesday, January 16. On Friday, April 13 the stock has “Hold” rating by Jefferies. On Wednesday, November 15 the rating was maintained by Bernstein with “Buy”. On Thursday, April 26 BMO Capital Markets maintained the shares of MRK in report with “Outperform” rating. On Monday, February 26 Jefferies maintained Merck & Co., Inc. (NYSE:MRK) rating. Jefferies has “Hold” rating and $56.0 target.

Merck & Co., Inc. (NYSE:MRK) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: